Yuexi Huang1, Nir Lipsman2, Michael L Schwartz2, Vibhor Krishna3, Francesco Sammartino3, Andres M Lozano3, Kullervo Hynynen1,4. 1. Physical Sciences, Sunnybrook Research Institute, 2075, Bayview Avenue, Toronto, ON M4N 3M5, Canada. 2. Division of Neurosurgery, Sunnybrook Health Sciences Centre, 2075, Bayview Avenue, Toronto, ON M4N 3M5, Canada. 3. Division of Neurosurgery, Toronto Western Hospital, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. 4. Department of Medical Biophysics, University of Toronto, 101 College Street, Toronto, ON M5G 1L7, Canada.
Abstract
PURPOSE: To correlate the accumulated thermal dose (ATD) with lesion size in magnetic resonance (MR)-guided focused ultrasound (MRgFUS) thalamotomy to help guide future clinical treatments. MATERIALS AND METHODS: Thirty-six patients with medication-refractory essential tremor were treated using a commercial MRgFUS brain system (ExAblate 4000, InSightec) in a 3T MR scanner (MR750, GE Healthcare). Intraoperative MR-thermometry was performed to measure the induced temperature and thermal dose distributions (thermal coefficient = -0.00909 ppm/°C). The ATD was calculated over multiple sonications with appropriate corrections for spatial-shifting artifacts. The ATD profile sizes obtained for dose values of 17, 40, 100, 200, and 240 cumulative equivalent minutes at 43°C (CEM) were correlated with the corresponding lesion sizes measured via axial T1- and T2-weighted MR images acquired 1 day post-treatment. RESULTS: Of a total of 232 included sonications, 83 required corrections for off-resonance-induced spatial-shifting artifacts (correction range = [1.1,2.2] mm). The mean lesion sizes measured on T2-weighted MR images (6.2 ± 1.3 mm, mean ± SD) were 15% larger than those measured on corresponding T1-weighted MR images (5.3 ± 1.2 mm, mean ± SD). The ATD values that provided the best correlations with the measured lesion sizes on T2- and T1-weighted MR images were 100 and 200 CEM, respectively. CONCLUSION: The ATD was correlated with lesion size measured 1 day following MRgFUS thalamotomy for essential tremor. These data provide useful information for predicting brain lesion size and determining treatment endpoints in future clinical MRgFUS procedures.
PURPOSE: To correlate the accumulated thermal dose (ATD) with lesion size in magnetic resonance (MR)-guided focused ultrasound (MRgFUS) thalamotomy to help guide future clinical treatments. MATERIALS AND METHODS: Thirty-six patients with medication-refractory essential tremor were treated using a commercial MRgFUS brain system (ExAblate 4000, InSightec) in a 3T MR scanner (MR750, GE Healthcare). Intraoperative MR-thermometry was performed to measure the induced temperature and thermal dose distributions (thermal coefficient = -0.00909 ppm/°C). The ATD was calculated over multiple sonications with appropriate corrections for spatial-shifting artifacts. The ATD profile sizes obtained for dose values of 17, 40, 100, 200, and 240 cumulative equivalent minutes at 43°C (CEM) were correlated with the corresponding lesion sizes measured via axial T1- and T2-weighted MR images acquired 1 day post-treatment. RESULTS: Of a total of 232 included sonications, 83 required corrections for off-resonance-induced spatial-shifting artifacts (correction range = [1.1,2.2] mm). The mean lesion sizes measured on T2-weighted MR images (6.2 ± 1.3 mm, mean ± SD) were 15% larger than those measured on corresponding T1-weighted MR images (5.3 ± 1.2 mm, mean ± SD). The ATD values that provided the best correlations with the measured lesion sizes on T2- and T1-weighted MR images were 100 and 200 CEM, respectively. CONCLUSION: The ATD was correlated with lesion size measured 1 day following MRgFUS thalamotomy for essential tremor. These data provide useful information for predicting brain lesion size and determining treatment endpoints in future clinical MRgFUS procedures.
Authors: Pavel S Yarmolenko; Eui Jung Moon; Chelsea Landon; Ashley Manzoor; Daryl W Hochman; Benjamin L Viglianti; Mark W Dewhirst Journal: Int J Hyperthermia Date: 2011 Impact factor: 3.914
Authors: W Jeffrey Elias; Diane Huss; Tiffini Voss; Johanna Loomba; Mohamad Khaled; Eyal Zadicario; Robert C Frysinger; Scott A Sperling; Scott Wylie; Stephen J Monteith; Jason Druzgal; Binit B Shah; Madaline Harrison; Max Wintermark Journal: N Engl J Med Date: 2013-08-15 Impact factor: 91.245
Authors: M Wintermark; J Druzgal; D S Huss; M A Khaled; S Monteith; P Raghavan; T Huerta; L C Schweickert; B Burkholder; J J Loomba; E Zadicario; Y Qiao; B Shah; J Snell; M Eames; R Frysinger; N Kassell; W J Elias Journal: AJNR Am J Neuroradiol Date: 2013-12-26 Impact factor: 3.825
Authors: Isabelle Saniour; Fraser J L Robb; Victor Taracila; Vishwas Mishra; Jana Vincent; Henning U Voss; Michael G Kaplitt; J Levi Chazen; Simone Angela Winkler Journal: IEEE Access Date: 2022-02-25 Impact factor: 3.476
Authors: Steven P Allen; Francesco Prada; Zhiyuan Xu; Jeremy Gatesman; Xue Feng; Helen Sporkin; Yekaterina Gilbo; Sydney DeCleene; Kim Butts Pauly; Craig H Meyer Journal: Magn Reson Med Date: 2020-11-11 Impact factor: 3.737